Mechanism of Action of Tissue Plasminogen Activator (tPA)
Core Enzymatic Mechanism
- tPA is a serine protease enzyme that converts plasminogen to plasmin in a fibrin-dependent manner, with its activity enhanced by 3 orders of magnitude (1000-fold) when bound to fibrin, thereby initiating localized fibrinolysis 1, 2, 3
- tPA cleaves plasminogen to generate plasmin, the active enzyme responsible for degrading fibrin clots into soluble fibrin degradation products (FDPs) 4, 5
- The conversion occurs through limited proteolysis of the zymogen plasminogen to the enzymatically active plasmin 1
Fibrin-Dependent Activation: The Critical Cofactor
- tPA binds to fibrin with high affinity, forming a plasminogen-tPA-fibrin ternary complex that improves plasminogen activation efficiency by approximately 1000-fold compared to activation without fibrin 1, 2, 3
- The presence of fibrin as a cofactor largely dictates overall fibrinolytic activity, making tPA highly selective for clot-bound plasminogen rather than circulating plasminogen 1, 2
Pharmacokinetic Properties
Regulation and Inhibition
- tPA is rapidly inhibited by plasminogen activator inhibitor-1 (PAI-1), forming tPA-PAI-1 complexes with a half-life of approximately 5 minutes 1, 3
- The tPA-PAI-1 complex undergoes hepatic clearance, and elevated complex levels directly indicate decreased free tPA concentration and reduced fibrinolytic potential 1, 3
- Measurable elevation of tPA-PAI-1 complex is a risk factor for cardiovascular diseases, as most circulating tPA exists in this inhibited form in pathological states 3, 7